Adicet Bio GAAP EPS of -$0.34 misses by $0.04

2 hours ago 1

Adicet Bio press release (NASDAQ:ACET): Q2 GAAP EPS of -$0.34 misses by $0.04.
Cash, cash equivalents and short-term investments were $125.0 million as of June 30, 2025, compared to $176.3 million as of December 31, 2024. The Company expects that current cash, cash equivalents and short-term investments as of June 30, 2025, will be sufficient to fund its operating expenses into the fourth quarter of 2026.

Recommended For You